Evidence map›Paper›PMID 34002273›Full record

ArticleAnalytical and bioanalytical chemistry2021

Sample preparation strategy for the detection of steroid-like compounds using MALDI mass spectrometry imaging: pulmonary distribution of budesonide as a case study.

Riccardo Zecchi, Pietro Franceschi, Laura Tigli, Davide Amidani, Chiara Catozzi, Francesca Ricci, Fabrizio Salomone, Giuseppe Pieraccini, Barbara Pioselli, Valentina Mileo

Open access · hybridAbstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Mass Spectrometry Imaging of Cholesterol and Oxysterols.Advances in experimental medicine and biology · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Riccardo Zecchi *Mass Spectrometry Center, Department of Health Sciences, University of Florence, Viale G. Pieraccini 6, 50139, Florence, Italy. riccardo.zecchi@unifi.it.ORCID http://orcid.org/0000-0001-9338-9956
Pietro Franceschi *Unit of Computational Biology, Research and Innovation Centre, Fondazione E. Mach, S. Michele all'Adige, 38198, Trento, Italy.
Laura TigliPreclinical R&D, Chiesi Farmaceutici, 43122, Parma, Italy.
Davide AmidaniPreclinical R&D, Chiesi Farmaceutici, 43122, Parma, Italy.
Chiara CatozziPreclinical R&D, Chiesi Farmaceutici, 43122, Parma, Italy.
Francesca RicciPreclinical R&D, Chiesi Farmaceutici, 43122, Parma, Italy.
Fabrizio SalomonePreclinical R&D, Chiesi Farmaceutici, 43122, Parma, Italy.
Giuseppe PieracciniMass Spectrometry Center, Department of Health Sciences, University of Florence, Viale G. Pieraccini 6, 50139, Florence, Italy.
Barbara PioselliPreclinical R&D, Chiesi Farmaceutici, 43122, Parma, Italy.
Valentina MileoPreclinical R&D, Chiesi Farmaceutici, 43122, Parma, Italy.
Chiesi Foundation · ITUniversity of Florence · ITFondazione Edmund Mach · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corticosteroids as budesonide can be effective in reducing topic inflammation processes in different organs. Therapeutic use of budesonide in respiratory diseases, like asthma, chronic obstructive pulmonary disease, and allergic rhinitis is well known. However, the pulmonary distribution of budesonide is not well understood, mainly due to the difficulties in tracing the molecule in lung samples without the addition of a label. In this paper, we present a matrix-assisted laser desorption/ionization mass spectrometry imaging protocol that can be used to visualize the pulmonary distribution of budesonide administered to a surfactant-depleted adult rabbit. Considering that budesonide is not easily ionized by MALDI, we developed an on-tissue derivatization method with Girard's reagent P followed by ferulic acid deposition as MALDI matrix. Interestingly, this sample preparation protocol results as a very effective strategy to raise the sensitivity towards not only budesonide but also other corticosteroids, allowing us to track its distribution and quantify the drug inside lung samples.

Indexed as

AnimalsBudesonideGlucocorticoidsIndicators and ReagentsLungRabbitsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSteroidsBudesonideGlucocorticoidsIndicators and ReagentsSteroidsBudesonideFerulic acidGirard reagentMass spectrometry imagingOn-tissue derivatizationPulmonary drug distribution

Identifiers

PMID34002273
PMCPMC8222037
OpenAlexW3161269159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.